Certain Stock Options of Akero Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUN-2024.
Details:
The directors, executive officers and certain stockholders affiliated with our directors have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each of these persons or entities, with limited exceptions, for a period of 90 days after the date of this prospectus supplement